Prevention and Therapy of Diabetic Complications

Illustration of the kidneysProgram Leader: Dr. Bruce Perkins

This program promotes the collaborative research of investigators involved in the field of diabetes complications at the University of Toronto and its fully affiliated academic teaching hospitals and research institutes. The program spans cell biology animal models and human trials featuring a comprehensive and interdisciplinary research program. A major focus of the program is diabetic nephropathy (kidney disease) in which the University of Toronto has an internationally recognized group of scientists.

A major outgrowth of the BBDC’s strength in diabetes complications was the awarding of a University of Toronto led multimillion dollar national  SPOR (Strategy for Patient-Oriented Research) Network in Diabetes and Its Related Complications.  Awarded in 2016, the SPOR Network is now named Diabetes Action Canada.

Many members of the BBDC are team members of DAC and are actively involved in its research and Knowledge Translation activities.  DAC’s activities are extensive and include clinical trials, informatics, development of new tools and therapies for diabetes complications, knowledge translation and training, to mention just some of the activities.  Much of the work focuses on targeted Intervention of diabetic complications, testing new therapies, imaging techniques, focus on population research, implementation science, knowledge translation, health economics research and health policy.  Together with the BBDC’s Prevention and Therapy of Diabetic Complications Program, DAC is an organization that is rapidly gaining recognition nationally as a major force for the prevention of diabetes complications.